APTO
Income statement / Annual
Last year (2023), Aptose Biosciences Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Aptose Biosciences Inc.'s net income was -$51.21 M.
See Aptose Biosciences Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$474,545.00 |
$507,079.00 |
$616,527.00 |
$646,435.00 |
$627,251.00 |
$83,512.00 |
$89,092.00 |
$114,835.00 |
$69,109.00 |
$0.00 |
| Gross Profit |
-$474,545.00 |
-$507,079.00 |
-$616,527.00 |
-$646,435.00 |
-$627,251.00 |
-$83,512.00 |
-$89,092.00 |
-$114,835.00 |
-$69,109.00 |
$0.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$36.77 M
|
$28.09 M
|
$45.99 M
|
$29.29 M
|
$16.84 M
|
$18.73 M
|
$6.27 M
|
$7.68 M
|
$4.51 M
|
$3,558.63
|
| General & Administrative
Expenses |
$15.59 M
|
$14.43 M
|
$19.32 M
|
$26.35 M
|
$9.90 M
|
$10.32 M
|
$5.50 M
|
$6.13 M
|
$7.05 M
|
$8,203.80
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$15.59 M
|
$14.43 M
|
$19.32 M
|
$26.35 M
|
$9.90 M
|
$10.32 M
|
$5.50 M
|
$6.13 M
|
$7.05 M
|
$8,203.80
|
| Other Expenses |
$0.00 |
$81,000.00 |
$138,000.00 |
$135,000.00 |
$122,000.00 |
$53,000.00 |
$50,000.00 |
$79,607.00 |
$48,281.00 |
$0.00 |
| Operating Expenses |
$52.36 M |
$42.60 M |
$65.45 M |
$55.77 M |
$26.86 M |
$29.11 M |
$11.83 M |
$13.89 M |
$11.60 M |
$11,830.00 |
| Cost And Expenses |
$52.36 M |
$42.60 M |
$65.45 M |
$55.77 M |
$26.86 M |
$29.11 M |
$11.83 M |
$13.89 M |
$11.60 M |
$11,830.00 |
| Interest Income |
$1.15 M |
$788,000.00 |
$94,000.00 |
$522,000.00 |
$574,000.00 |
$283,000.00 |
$165,000.00 |
$78,119.00 |
$206,097.00 |
$327.15 |
| Interest Expense |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$49,103.00 |
$30,986.00 |
$0.00 |
| Depreciation &
Amortization |
$88,000.00
|
$507,079.00
|
$616,527.00
|
$646,435.00
|
$627,251.00
|
$83,512.00
|
$89,092.00
|
$114,835.00
|
$48,281.00
|
$32.57
|
| EBITDA |
-$52.27 M
|
-$39.66 M
|
-$64.16 M
|
-$57.51 M
|
-$26.26 M
|
-$27.31 M
|
-$11.61 M
|
-$13.78 M
|
-$10.43 M
|
-$11.73 M
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$1.15 M
|
$779,000.00
|
$93,000.00
|
$530,000.00
|
$580,000.00
|
$239,000.00
|
$165,000.00
|
$60,600.00
|
$1.06 M
|
$259.05
|
| Income Before Tax |
-$51.21 M |
-$41.82 M |
-$65.35 M |
-$55.24 M |
-$26.28 M |
-$28.87 M |
-$11.66 M |
-$13.86 M |
-$10.54 M |
-$11,503.38 |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00 |
-$770,000.00 |
-$93,000.00 |
-$530,000.00 |
-$580,000.00 |
-$44,000.00 |
$97,000.00 |
-$35,227.83 |
$30,986.00 |
$0.00 |
| Net Income |
-$51.21 M |
-$41.05 M |
-$65.26 M |
-$54.71 M |
-$25.70 M |
-$28.87 M |
-$11.66 M |
-$13.86 M |
-$10.54 M |
-$11,503.38 |
| Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| EPS |
-7.58 |
-6.67 |
-10.99 |
-10.03 |
-7.68 |
-12.97 |
-7.84 |
-16.32 |
-13.29 |
-0.0149 |
| EPS Diluted |
-7.58 |
-6.67 |
-10.99 |
-10.03 |
-7.68 |
-12.97 |
-7.84 |
-16.31 |
-13.28 |
-0.0149 |
| Weighted Average Shares
Out |
$6.76 M
|
$6.15 M
|
$5.94 M
|
$5.46 M
|
$3.34 M
|
$2.23 M
|
$1.49 M
|
$849,000.00
|
$793,000.00
|
$773,000.00
|
| Weighted Average Shares
Out Diluted |
$6.76 M
|
$6.15 M
|
$5.94 M
|
$5.46 M
|
$3.34 M
|
$2.23 M
|
$1.49 M
|
$849,533.00
|
$793,733.00
|
$773,667.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
